Navigation Links
Concordia University receives more than $22 million for genomics research
Date:4/20/2009

Montreal, April 20, 2009 Concordia University is pleased to announce that researchers Adrian Tsang and Vincent Martin of the Centre for Structural and Functional Genomics have been awarded more than $22 million to further advance the innovative genome research being conducted at Concordia. This investment results from the Genome Canada Applied Genomics Research in Bioproducts or Crops (ABC) competition launched last year and will include major contributions from both Genome Canada and Gnome Qubec.

Dr. Tsang was awarded $17.4 million for his project on the discovery of novel approaches for biofuel production. This represents the largest single budget of the ABC competition and the most significant investment in a project toward environmental sustainability in Genome Canada's history. Dr. Martin's project on identifying novel high-value plant-derived bioproducts, which he co-leads with University of Calgary researcher Peter Facchini, was awarded $13.6 million with more than $4.6 million for Dr Martin's activities at Concordia.

The announcement was made today in Saskatoon by the Federal Minister of State (Science and Technology) Gary Goodyear and Chairman of the Board of Genome Canada Dr. Calvin Stiller.

"This accomplishment confirms Concordia's exceptional leadership in genomic research," says President and Vice-Chancellor Judith Woodsworth. "These remarkable grants will truly strengthen the work being done by these talented researchers which, in turn, will create groundbreaking solutions for serious environmental issues."

"Researchers like Adrian Tsang and Vincent Martin make Quebec proud", added Jean-Marc Proulx, president and CEO of Gnome Qubec. "These results confirm the critical importance of genomics in leading edge sectors and its contribution to solving problems linked to sustained development. Congratulations to these internationally recognized scientists".


'/>"/>

Contact: Chris Mota
chris.mota@concordia.ca
514-848-2424 x4884
Concordia University
Source:Eurekalert

0

GOOD

Page: 1

Related biology news :

1. A world-first in solar technology unveiled at Concordia University
2. Concordia University leads academic team for national Cellulosic Biofuels Network
3. A study by the MUHC and McGill University opens a new door to understanding cancer
4. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
5. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
6. Bioengineers at University of Pennsylvania devise nanoscale system to measure cellular forces
7. Binghamton University researchers investigate evolving malaria resistance
8. Antioxidant to retard wrinkles discovered by Hebrew University researcher
9. Society for General Microbiology 161st Meeting, University of Edinburgh
10. Boston University biomedical engineers find chink in bacterias armor
11. KAUST and American University in Cairo to collaborate on research and academic development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...AMBRIDGE, Mass. (November 26, 2009) Whitehead res...en for human cells to pinpoint specific genes and ...er in Science . , In most human cell cultures g... the father and one from the mother. Gene inactiva...when one copy is inactivated, the second copy usua...
(Date:11/25/2009)...hrelin, a hormone produced in the stomach, may be ...ent of Parkinson,s disease, Yale School of Medicin...ent issue of the Journal of Neuroscience . , Pa...opamine neurons in an area of the midbrain known a...opamine production. Reduced production of dopamin...
(Date:11/25/2009)...ADISON, WI, NOVEMBER 25, 2009 Soil is the linchpi... and hydrosphere meet. Despite that, many students...but nothing more. Soil science educators are chall...blic recognize the critical importance of soil in ...oil science and earth science teachers at Universi...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2Novo Nordisk Wins Design Award for NovoTwist 28TM 29 Needle 5671 1Novo Nordisk Wins Design Award for NovoTwist 28TM 29 Needle 5671 2Novo Nordisk Wins Design Award for NovoTwist 28TM 29 Needle 5671 3UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 1UC San Diego researchers reverse pulmonary arterial hypertension in mouse models 60038 2Testicular tumors may explain why some diseases are more common in children of older fathers 10512 1Testicular tumors may explain why some diseases are more common in children of older fathers 10512 2
...ffering chronic obstructive pulmonary disease (COP... finding that contradicts the conventional wisdom ... "Evidence for attempted regional elastic fiber re..., Kristin Castillo, Alexander Patterson and Richar... Joel Cooper of the University of Pennsylvania, Ph...
...ring researchers at UC San Diego report in the Nov...changes in a bacterial genome, observed in near-re...y published static "snapshots" of the genome seque...harmless to those that cause plague, but this new ... , "Paleontologists look at the fossil record to s...
...rsity Medical Center have visualized in a living a...to dice and splice genetic material to create uniq...indings, made in mice, help explain a key wonder o... cell of an individual’s body can produce differen...varied proteins, in turn, dictate the function of ...
Other Biology News:Lungs try to repair damaged elastic fibers 2Novel experiment documents evolution of genome in near-real time 2Novel experiment documents evolution of genome in near-real time 3Living view in animals shows how cells decide to make proteins 2Living view in animals shows how cells decide to make proteins 3
(Date:11/24/2009)... , SEATTLE, Nov. 24 Blue Mar...and the Odessa Public Development Authority (OPDA)...ate,s Community Economic Revitalization Board (CER...e state,s first specialty biochemical biorefinery ...ll significantly speed the development of our bior...
(Date:11/24/2009)... , , Primary efficacy endpoint has been ...ent endometrial cancer, , QUEBEC CITY, Nov. 2...NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a globa...herapy and oncology, today announced positive effi...ytotoxic peptide conjugate, AEZS-108 (formerly AN-...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-Firs...he global specialty biopharmaceutical company, tod...ropean Medicines Agency for,velaglucerase alfa, th...ent,for the treatment of Type 1 Gaucher disease. T...cerase alfa that has been submitted, with previous...
(Date:11/24/2009)... , REDWOOD CITY, Calif., Nov. 24 /PRNewswi...DX ) today announced that Randy Scott, Genomic Hea... Annual Piper Jaffray Health Care Conference in Ne...a.m. ET. ,, To access the live and subsequentl...Investor Relations section of Genomic Health,s web...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...N.C., Nov. 5 As biopharmaceutical,companies conti... efforts,are placed on strategy and execution from...luations largely focus on revenue growth and littl...launch excellence, a recent study,was conducted by...ith,insights available in the newly published repo...
...-DAC(TM):Exendin-4 Data in December - - PC-Insuli...RNewswire-FirstCall/ - ConjuChem Biotechnologies,I...ete for its Phase II,clinical trial of PC-DAC(TM):...ouble-blind, placebo-controlled, multiple dose stu... months of weekly injections of,PC-DAC(TM):Exendin...
...., Nov. 5 BioMarin,Pharmaceutical Inc. (Nasdaq: ... Chief Executive Officer of BioMarin, will present... Healthcare Conference in Phoenix,Arizona on Wedne...ested parties may access a live audio webcast of t... BioMarin website, http://www.BMRN.com .,A replay...
Other Biology Technology:New Study Provides Key Findings for Biopharma Product Launch Evaluation 2ConjuChem Provides Development Update 2ConjuChem Provides Development Update 3BioMarin to Present at the Credit Suisse Healthcare Conference 2
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)
Essential Data: Gel Electrophoresis from Promega
Human MMP-7 (Total) ELISpot Kit from R&D Systems
...Kit, 1. Select from homogeneous and gradient polya...enaturing, native, and isoelectric focusing gels.S...gels, buffer strips, and staining kits.Achieve det...opes with ready-to-use silver staining kits. Categ...
Biology Products: